Skip to main content

Advertisement

SpringerLink
Log in

Mizoribine for crescentic glomerulonephritis with sarcoidosis: effectiveness not only for urinalysis abnormalities but also for hilar lymph node enlargement

  • Case Report
  • Published:
Modern Rheumatology

Abstract

Sarcoidosis is a multisystem disease related to helper T cell responses. We recently experienced the case of a 57-year-old woman with sarcoidosis complicated by crescentic glomerulonephritis with low levels of myeloperoxidase-antineutrophil cytoplasmic antibody. We herein describe the details of her clinical course and discuss the effectiveness of mizoribine, which has an immunosuppressive effect equivalent to that of mycophenolate mofetil, not only for urinalysis abnormalities but also for hilar lymph node enlargement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357:2153–65.

    Article  PubMed  CAS  Google Scholar 

  2. Berliner AR, Haas M, Choi MJ. Sarcoidosis: the nephrologist’s perspective. Am J Kidney Dis. 2006;48:856–70.

    Article  PubMed  Google Scholar 

  3. Gobel U, Kettritz R, Schneider W, Luft F. The protean face of renal sarcoidosis. J Am Soc Nephrol. 2001;12:616–23.

    PubMed  CAS  Google Scholar 

  4. van Uum SH, Cooreman MP, Assmann KJ, Wetzels JF. A 58-year-old man with sarcoidosis complicated by focal crescentic glomerulonephritis. Nephrol Dial Transpl. 1997;12:2703–7.

    Article  Google Scholar 

  5. Auinger M, Irsigler K, Breiteneder S, Ulrich W. Normocalcaemic hepatorenal sarcoidosis with crescentic glomerulonephritis. Nephrol Dial Transpl. 1997;12:1474–7.

    Article  CAS  Google Scholar 

  6. Sonda K, Takahashi K, Tanabe K, Funchinoue S, Hayasaka Y, Kawaguchi H, et al. Clinical pharmacokinetic study of mizoribine in renal transplantation patients. Transpl Proc. 1996;28:3643–8.

    CAS  Google Scholar 

  7. Kawasaki Y. Mizoribine: a new approach in the treatment of renal disease. Clin Dev Immunol. 2009;2009:681482.

    Article  PubMed  CAS  Google Scholar 

  8. Hirayama K, Kobayashi M, Hashimoto Y, Usui J, Shimizu Y, Hirayama A, et al. Treatment with the purine synthesis inhibitor mizoribine for ANCA-associated renal vasculitis. Am J Kidney Dis. 2004;44:57–63.

    Article  PubMed  CAS  Google Scholar 

  9. Ho LP, Urban BC, Thickett DR, Davies RJO, McMichael AJ. Deficiency of a subset of T cells with immunoregulatory properties in sarcoidosis. Lancet. 2005;365:1062–72.

    PubMed  CAS  Google Scholar 

  10. Miyagaki T, Asano Y, Shibata S, Ohno Y, Tsunemi Y, Saeki H, et al. The development of Th1-mediated sarcoidosis improves the clinical course of Th2-mediated atopic dermatitis. Mod Rheumatol. 2011;21:406–9.

    Article  PubMed  CAS  Google Scholar 

  11. Tipping PG, Kitching AR. Glomerulonephritis, Th1 and Th2: what’s new? Clin Exp Immunol. 2005;142:207–15.

    Article  PubMed  CAS  Google Scholar 

  12. Wilde B, van Paassen P, Witzke O, Tervaert JW. New pathophysiological insights and treatment of ANCA-associated vasculitis. Kidney Int. 2011;79:599–612.

    Article  PubMed  CAS  Google Scholar 

  13. Gomez-Puerta JA, Bosch X. Anti-neutrophil cytoplasmic antibody pathogenesis in small-vessel vasculitis: an update. Am J Pathol. 2009;175:1790–8.

    Article  PubMed  CAS  Google Scholar 

  14. Franssen CF, Stegeman CA, Oost-Kort WW, Kallenberg CG, Limburg PC, Tiebosch A, et al. Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis. J Am Soc Nephrol. 1998;9:1915–23.

    PubMed  CAS  Google Scholar 

  15. Nakabayashi K. Slowly progressive, not rapidly progressive, MPO-ANCA positive glomerulonephritis and its characteristics. Intern Med. 2002;41:418–9.

    Article  PubMed  Google Scholar 

  16. Aoyama T, Shimizu T, Matsuo T, Sakamoto H, Kamata K, Higashihara M, et al. MPO-ANCA-positive slowly progressive glomerulonephritis with focal tuft necrosis and crescents. Intern Med. 2002;41:458–62.

    Article  PubMed  Google Scholar 

  17. Yoshida M. Antineutrophil cytoplasmic antibody (ANCA) associated vasculitis: from molecular analysis to bedside. Intern Med. 2002;41:47–9.

    Article  PubMed  CAS  Google Scholar 

  18. Altschuler EL. The first case of sarcoidosis treated with mycophenolate mofetil. Br J Dermatol. 2003;149:442; discussion 442–443.

    Google Scholar 

  19. Moudgil A, Przygodzki RM, Kher KK. Successful steroid-sparing treatment of renal limited sarcoidosis with mycophenolate mofetil. Pediatr Nephrol. 2006;21:281–5.

    Article  PubMed  Google Scholar 

  20. Yumura W, Suganuma S, Uchida K, Moriyama T, Otsubo S, Takei T, et al. Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis. Clin Nephrol. 2005;64:28–34.

    PubMed  CAS  Google Scholar 

  21. Kuroda T, Kobayashi D, Sato H, Oyanagi A, Wada Y, Murakami S, et al. Mizoribine therapy in a patient with lupus nephritis: the association between mizoribine concentration and peritoneal dialysis. Mod Rheumatol. 2010;20:296–300.

    Article  PubMed  Google Scholar 

  22. Kaneko T, Hirama A, Ueda K, Fujino T, Utsumi K, Iino Y, et al. Methylprednisolone pulse therapy combined with mizoribine following tonsillectomy for immunoglobulin A nephropathy: clinical remission rate, steroid sparing effect, and maintenance of renal function. Clin Exp Nephrol. 2011;15:73–8.

    Article  PubMed  CAS  Google Scholar 

  23. Ito S, Harada T, Nakamura T, Imagawa T, Nagahama K, Sasaki T, et al. Mizoribine for renal sarcoidosis: effective steroid tapering and prevention of recurrence. Pediatr Nephrol. 2009;24:411–4.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We are grateful to Prof. Masatoshi Tateno (Department of Pathology, Asahikawa Medical University) for excellent support for making diagnosis.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Division of Cardiology, Nephrology, Pulmonology and Neurology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan

    Maki Kabara, Naoki Nakagawa, Motoki Matsuki, Junko Chinda, Takayuki Fujino & Naoyuki Hasebe

Authors
  1. Maki Kabara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naoki Nakagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Motoki Matsuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Junko Chinda
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takayuki Fujino
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Naoyuki Hasebe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Naoki Nakagawa.

About this article

Cite this article

Kabara, M., Nakagawa, N., Matsuki, M. et al. Mizoribine for crescentic glomerulonephritis with sarcoidosis: effectiveness not only for urinalysis abnormalities but also for hilar lymph node enlargement. Mod Rheumatol 23, 146–150 (2013). https://doi.org/10.1007/s10165-012-0614-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10165-012-0614-0

Keywords

Search

Navigation